Retractable Technologies, Inc. (NYSE:RVP) CEO Purchases $14,034.79 in Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw purchased 18,227 shares of Retractable Technologies stock in a transaction on Monday, February 3rd. The stock was bought at an average cost of $0.77 per share, with a total value of $14,034.79. Following the transaction, the chief executive officer now directly owns 15,037,535 shares of the company’s stock, valued at approximately $11,578,901.95. The trade was a 0.12 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link.

Retractable Technologies Trading Down 1.6 %

Retractable Technologies stock opened at $0.79 on Friday. The firm has a fifty day moving average price of $0.71 and a two-hundred day moving average price of $0.80. Retractable Technologies, Inc. has a fifty-two week low of $0.56 and a fifty-two week high of $1.34. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92.

Analyst Upgrades and Downgrades

Separately, StockNews.com assumed coverage on Retractable Technologies in a report on Friday. They set a “hold” rating on the stock.

Institutional Trading of Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC acquired a new stake in shares of Retractable Technologies, Inc. (NYSE:RVP) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned about 0.12% of Retractable Technologies as of its most recent filing with the Securities & Exchange Commission. 7.58% of the stock is owned by institutional investors and hedge funds.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.